Back to Search

GIOVANNI MELILLO, MD

MD

Hematology & Oncology Physician

NPI: 1205371135Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

D0056750(MD)

Research & Publications (20)

Hypoxia-inducible factor 1 inhibitors.
PMID 17998065·Methods Enzymol·2007
7-preclinical
Targeting hypoxia cell signaling for cancer therapy.
PMID 17415529·Cancer Metastasis Rev·2007
6-review
Inhibiting hypoxia-inducible factor 1 for cancer therapy.
PMID 16940159·Mol Cancer Res·2006
6-review
Meeting report: exploiting the tumor microenvironment for therapeutics.
PMID 16651404·Cancer Res·2006
7-preclinical
HIF-1: a target for cancer, ischemia and inflammation--too good to be true?
PMID 14712079·Cell Cycle·2004
6-review
Development of HIF-1 inhibitors for cancer therapy.
PMID 19674190·J Cell Mol Med·2009
6-review
Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients.
PMID 19336532·Physiol Genomics·2009
8-other
A comparison between sevoflurane and desflurane anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery.
PMID 19608833·Anesth Analg·2009
4-observational
Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome.
PMID 19362550·Exp Cell Res·2009
8-other
Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.
PMID 19394890·Drug Resist Updat·2009
6-review
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
PMID 19584228·Mol Cancer Ther·2009
7-preclinical
Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii.
PMID 19405508·J Nat Prod·2009
8-other
Synergystic induction of HIF-1alpha transcriptional activity by hypoxia and lipopolysaccharide in macrophages.
PMID 18212534·Cell Cycle·2008
7-preclinical
Separation and SAR study of HIF-1alpha inhibitory tubulosines from Alangium cf. longiflorum.
PMID 18302092·Planta Med·2008
8-other
Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.
PMID 18172321·Cancer Res·2008
8-other
Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide.
PMID 18728285·J Natl Cancer Inst·2008
7-preclinical
Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
PMID 17555795·Hum Pathol·2007
8-other
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice.
PMID 17656654·J Leukoc Biol·2007
4-observational
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
PMID 17875771·Clin Cancer Res·2007
3-trial
Early postoperative complications after intracranial surgery: comparison between total intravenous and balanced anesthesia.
PMID 17893573·J Neurosurg Anesthesiol·2007
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2554 BEAR DEN RD
FREDERICK, MD 21701

Location

Practice Location

2554 BEAR DEN RD, FREDERICK, MD
(301) 639-2190

Quick Facts

NPI
1205371135
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile